Identification of Hypertension Predictors and Application to Hypertension Prediction in an Urban Han Chinese Population: A Longitudinal Study, 2005–2010
ORIGINAL RESEARCH — Volume 12 — October 29, 2015
PEER REVIEWED
Figure 1. Prevalence of hypertension, by age, at baseline, in an urban Han population, China, 2005–2010.
Age, y | Hypertension Prevalence, % | |
---|---|---|
Men | Women | |
18 | 17.91 | 2.08 |
19 | 10.23 | 0 |
20 | 15.44 | 4.92 |
21 | 8.6 | 0.69 |
22 | 12.02 | 1.78 |
23 | 12.46 | 2.65 |
24 | 12.54 | 2.91 |
25 | 12.46 | 1.27 |
26 | 11.47 | 2.29 |
27 | 12.91 | 2.2 |
28 | 13.09 | 2.44 |
29 | 12.45 | 3.09 |
30 | 15.51 | 2.2 |
31 | 14.29 | 3.05 |
32 | 16.94 | 3.04 |
33 | 15.5 | 2.93 |
34 | 17.29 | 3.17 |
35 | 20.71 | 3.74 |
36 | 21.73 | 3.7 |
37 | 17.62 | 4.38 |
38 | 24.19 | 4.66 |
39 | 25.43 | 4.06 |
40 | 27.93 | 6.99 |
41 | 27.77 | 7.32 |
42 | 28.43 | 8.98 |
43 | 30.2 | 9.79 |
44 | 30.46 | 10.73 |
45 | 33.55 | 13.02 |
46 | 35.34 | 13.72 |
47 | 35.13 | 14.55 |
48 | 39.21 | 18.88 |
49 | 35.91 | 18.22 |
50 | 37.45 | 21.62 |
51 | 40.97 | 24.39 |
52 | 41.46 | 26.11 |
53 | 40.85 | 27.83 |
54 | 43.43 | 32.16 |
55 | 43.27 | 32.58 |
56 | 43.24 | 33.78 |
57 | 44.41 | 41.92 |
58 | 49.64 | 42.96 |
59 | 46.72 | 45.53 |
60 | 48.8 | 45.95 |
61 | 48.34 | 44.26 |
62 | 53.5 | 46.58 |
63 | 55 | 54.62 |
64 | 53.31 | 54.97 |
65 | 55.68 | 53.95 |
66 | 58.91 | 58.79 |
67 | 58.59 | 53.8 |
68 | 64.62 | 53.09 |
69 | 62.35 | 60.38 |
70 | 64.94 | 62.96 |
71 | 64.99 | 68.25 |
72 | 63.95 | 62.41 |
73 | 71.99 | 68.16 |
74 | 71.12 | 70.61 |
75 | 71.35 | 69.83 |
76 | 71.97 | 69.68 |
77 | 79.4 | 67.8 |
78 | 74.42 | 75.42 |
79 | 70.62 | 73.86 |
80 | 72.4 | 68.63 |
81 | 64.89 | 75.61 |
82 | 70.68 | 71.74 |
83 | 77.27 | 58.06 |
84 | 70.59 | 81.82 |
85 | 60 | 68.42 |
For men: HSP = (0.097345 × body mass index) + (0.045604 × systolic blood pressure) + (0.051722 × diastolic blood pressure) + (0.147807 × fasting blood glucose) + (0.096384 × triglycerides) – (0.00694 × high-density lipoprotein cholesterol) + (0.007746 × hemoglobin) + (0.0022516 × hematocrit) + (0.05383 × white blood cell count) + (0.050579 × lymphocyte count) + (0.074163 × neutrophil granulocyte count) − 71.26765. For women: HSP = (0.114583 × body mass index) + (0.033556 × systolic blood pressure) + (0.045974 × diastolic blood pressure) + (0.118307 × fasting blood glucose) + (0.158433 × triglycerides) – (0.33512 × high-density lipoprotein cholesterol) + (0.017102 × hemoglobin) + (0.065664 × hematocrit) + (0.119985 × white blood cell count) + (0.26673 × lymphocyte count) – (0.111738 × neutrophil granulocyte count) − 66.90516.
Figure 2. The 5-year risk matrix for risk appraisal of hypertension by sex. Graphs A1 and B1 are absolute risk matrices for men and women, respectively; graphs A2 and B2 are relative absolute risk matrices for men and women, respectively. The dashed lines indicate discrimination criteria of absolute risk for predicting hypertension; the curved lines indicate mean absolute risk in the population. Abbreviation: HSP, hypertension synthetic predictor.
Appendix B shows ROC curves for hypertension prediction models, which are represented in the 2 graphs.
- Page last reviewed: October 29, 2015
- Page last updated: October 29, 2015
- Content source:
- Maintained By: